Skip to content

Effectiveness of Indo-SURFT in Reducing Addictive Substance Use in Women With Substance Use Disorders

Effectiveness of Indo-SURFT in Reducing Addictive Substance Use in Women With Substance Use Disorders: a Pilot Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06174714
Acronym
Indo-SURFT
Enrollment
30
Registered
2023-12-18
Start date
2024-08-31
Completion date
2025-03-31
Last updated
2024-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use Disorders

Brief summary

Relapse in women was associated with depression, interpersonal stress, and relationship conflict with others when compared with men. The differences in gender profiles with substance use disorders (SUD) leads to the need for management strategies that are sensitive to each gender. This is a challenge to build a new module that can be applied continuously by collaborating CBT and several other psychosocial interventions, such as motivational enhancement therapy. The investigators compiled Indonesia Substance Use Reduction for Female Therapy (Indo-SURFT). By implementing this module, it is hoped that it can provide short and long term effects and reduce the relapse rate in women with SUD.

Interventions

BEHAVIORALIndonesia Substance Use Reduction for Female Therapy (Indo-SURFT)

4 weeks of motivational interviewing/motivational enhancement therapy (MI) followed by 8 weeks cognitive behavioral therapy (CBT) using Indo-SURFT module.

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* women aged 18-59 years old * diagnosed with substance use disorders based on DSM-V or ICD-10

Exclusion criteria

* subjects with severe mental disorder or intellectual disability

Design outcomes

Primary

MeasureTime frameDescription
Abstinence from Substance Usepost-intervention (week 13)Timeline Follow Back (TLFB): to assess daily use of addictive substances by writing yes/no for 28 days. This data will be collected weekly retrospectively to reduce the risk of recall bias.
Decrease in Addiction Severitypre-intervention (week 0), and post-intervention (week 13)Addiction Severity Index (ASI), Indonesia version, measuring several domains: 1) Medical health (n= 11), 2) Employment/ support status (n= 24), 3 & 4) Drug/ alcohol use (n= 35), 5) Illegal activity/ legal status (n= 32), 6) Family/ social relationships (n= 38) and 7) Psychiatric health (n= 23). Lesser score indicates better outcome.
Improvement in Motivation to Changepre-intervention (week 0), and post-intervention (week 13)University of Rhode Island Change Assessment (URICA), measuring motivation to change with 4 domains: 1) pre-contemplation, 2) contemplation, 3) action, and 4) maintenance. A higher score indicates a better outcome.
Improvement in Substance Cravingpre-intervention (week 0), and post-intervention (week 13)Visual Analog Scale (VAS), measuring substance craving severity. Range 0 (no craving) - 100 (severe craving). A lower score indicates a better outcome.

Secondary

MeasureTime frameDescription
Improvement in Social Performancepre-intervention (week 0), and post-intervention (week 13)Personal and Social Performance (PSP), measuring social function. A lower score indicates a better outcome.
Improvement in Quality of Lifepre-intervention (week 0), and post-intervention (week 13)World Health Organization Quality of Life (WHOQOL), measuring individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. A higher score indicates a better outcome.
Improvement in Psychological Distresspre-intervention (week 0), and post-intervention (week 13)Self-Report Questionnaire-20 (SRQ-20), measuring non-specific psychological distress. Score range 0-20; Scores \>10 classified as mental distress. A lower score indicates a better outcome.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026